IRIS
PICCHIO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.534
EU - Europa 8.167
AS - Asia 6.609
SA - Sud America 1.712
Continente sconosciuto - Info sul continente non disponibili 489
AF - Africa 145
OC - Oceania 24
Totale 26.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.060
RU - Federazione Russa 3.762
SG - Singapore 2.306
CN - Cina 1.962
IT - Italia 1.381
BR - Brasile 1.354
SE - Svezia 834
HK - Hong Kong 796
VN - Vietnam 629
RO - Romania 540
BD - Bangladesh 363
ES - Italia 352
FR - Francia 331
DE - Germania 257
CA - Canada 230
GB - Regno Unito 212
FI - Finlandia 146
AR - Argentina 143
IN - India 118
MX - Messico 88
PL - Polonia 73
ID - Indonesia 66
EC - Ecuador 60
NL - Olanda 60
ZA - Sudafrica 57
IE - Irlanda 51
TR - Turchia 51
IQ - Iraq 45
JP - Giappone 43
AT - Austria 41
CO - Colombia 41
CR - Costa Rica 30
JM - Giamaica 29
PY - Paraguay 28
MD - Moldavia 27
CL - Cile 24
PE - Perù 23
PK - Pakistan 23
HN - Honduras 22
NP - Nepal 22
SA - Arabia Saudita 22
AU - Australia 21
UA - Ucraina 21
MY - Malesia 20
VE - Venezuela 20
MA - Marocco 17
PH - Filippine 16
UZ - Uzbekistan 16
JO - Giordania 14
DZ - Algeria 13
GT - Guatemala 13
IR - Iran 13
KE - Kenya 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
IL - Israele 11
TT - Trinidad e Tobago 11
AZ - Azerbaigian 10
BE - Belgio 10
PT - Portogallo 10
TN - Tunisia 10
UY - Uruguay 10
CZ - Repubblica Ceca 8
NI - Nicaragua 8
BO - Bolivia 7
RS - Serbia 7
CW - ???statistics.table.value.countryCode.CW??? 6
EU - Europa 6
KR - Corea 6
KZ - Kazakistan 6
OM - Oman 6
SV - El Salvador 6
AL - Albania 5
BB - Barbados 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GR - Grecia 5
PR - Porto Rico 5
TW - Taiwan 5
BG - Bulgaria 4
BZ - Belize 4
CI - Costa d'Avorio 4
GD - Grenada 4
GP - Guadalupe 4
LB - Libano 4
PA - Panama 4
PS - Palestinian Territory 4
SC - Seychelles 4
SN - Senegal 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
CY - Cipro 3
HU - Ungheria 3
KH - Cambogia 3
LV - Lettonia 3
SY - Repubblica araba siriana 3
AO - Angola 2
AW - Aruba 2
Totale 26.175
Salva come PNG Salva come JPEG
Città #
Dallas 3.118
Ashburn 1.037
Singapore 977
Moscow 799
Hong Kong 781
San Jose 760
Milan 497
Shanghai 376
Council Bluffs 327
Valencia 303
Hefei 299
New York 285
Beijing 280
Princeton 252
Lauterbourg 251
Lawrence 244
Ho Chi Minh City 207
Santa Clara 178
Hanoi 153
Los Angeles 138
São Paulo 119
Phoenix 116
Munich 100
Rome 88
Orem 79
Helsinki 73
Boardman 72
Brooklyn 59
Turku 59
Chicago 50
Dublin 50
Miano 50
Warsaw 49
Atlanta 44
Montreal 42
Rio de Janeiro 39
Naples 37
Toronto 37
Buffalo 36
London 36
Denver 35
Chennai 34
Da Nang 34
Tokyo 34
Frankfurt am Main 33
North Bergen 33
Seattle 33
Johannesburg 31
Washington 30
Manchester 29
Stockholm 29
Mexico City 28
The Dalles 28
Belo Horizonte 27
Poplar 27
Haiphong 25
Guangzhou 24
Houston 24
Nuremberg 24
Boston 23
Brasília 23
Amsterdam 22
Quito 22
West Jordan 22
Ankara 21
Curitiba 21
Dhaka 21
Philadelphia 21
Las Vegas 20
Turin 20
Charlotte 19
Kingston 19
San José 19
Lima 18
Columbus 17
Genoa 17
Mumbai 17
Shenzhen 17
Baghdad 16
Brescia 16
Guayaquil 16
Vienna 16
Barnet 15
Buenos Aires 15
Florence 15
New Delhi 15
Newark 15
Ninh Bình 15
Tashkent 15
Can Tho 14
Guarulhos 14
Manaus 14
Asunción 13
Bologna 13
Campinas 13
Porto Alegre 13
Amman 12
Bogotá 12
Goiânia 12
Hangzhou 12
Totale 13.749
Salva come PNG Salva come JPEG
Nome #
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.457
11C-choline PET/CT and PSA kinetics 1.401
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 286
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 213
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 211
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 208
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 203
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 198
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 197
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 192
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 182
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 173
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 173
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 172
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 165
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 158
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 157
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 155
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 155
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 154
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 153
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 152
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 148
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 146
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 145
18F-FDG uptake by prosthetic arterial grafts in large vessel vasculitis is not specific for active disease: results from a cohort study 143
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 143
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 142
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 140
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 139
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 138
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 137
18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience 137
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 136
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 135
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 135
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 135
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 134
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 134
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 134
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 133
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis 133
[F-18]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients 130
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 129
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 129
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 128
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 127
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 126
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 126
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 125
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 125
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 125
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 124
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 124
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 124
Hypoxia pathway: 18F-FAZA 123
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 123
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 122
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 121
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 119
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 118
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 118
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 117
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 116
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 116
Diagnosis of local recurrence after radical prostatectomy 115
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 112
Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment 112
The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer 107
CRITICAL ASSESSMENT OF THE PERFORMANCE OF PSA KINETICS FOR THE PREDICTION OF [11C]CHOLINE PET/CT IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 106
18F-FDG positron emission tomography compared with computed tomography in diagnosing recurrent ovarian carcinoma 106
Radiomics and artificial intelligence 105
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 105
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 104
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 104
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 102
3D Spatial resolution proprieties of Molecubes β-Cube: Characterization with different isotopes 100
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY 98
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 95
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy 94
FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease 94
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 93
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 92
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 91
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 90
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 89
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 88
Combined Use of TBNA and EBUS-TBNA in the Preoperative Staging of Lung Cancer Patients 84
Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques 83
Imaging in evaluation of response to neo-adjuvant treatment 83
Bone metastases are infrequent in patients with newly diagnosed prostate cancer: Analysis of their clinical and pathologic features 82
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 81
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 81
PET/MRI and prostate cancer 80
PSA doubling time for prediction of [C-11]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy 80
Increased Choline Uptake in Bronchioalveolar Cell Carcinoma with Negative FDG Uptake. A PET/CT and Pathology Study 80
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 80
18FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18FDG-PET)-GUIDED TARGET DELINEATION IN LUNG 79
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 78
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial 77
Totale 15.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022209 0 0 0 96 14 7 13 12 18 29 5 15
2022/20231.532 543 314 123 36 23 178 81 124 43 31 5 31
2023/20241.006 52 45 149 102 66 168 36 104 12 60 54 158
2024/20254.332 529 66 65 99 141 302 1.162 285 584 441 288 370
2025/202616.059 927 1.466 3.291 1.935 924 351 1.169 881 3.344 718 447 606
2026/20273.255 610 775 664 1.206 0 0 0 0 0 0 0 0
Totale 26.680